Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma
City of Hope Medical Center
City of Hope Medical Center
Universität des Saarlandes
City of Hope Medical Center
City of Hope Medical Center
Northwestern University
Stanford University
University of Nebraska
University of Nebraska
City of Hope Medical Center
University of Nebraska
University of Nebraska
City of Hope Medical Center
Fred Hutchinson Cancer Center
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota
Mayo Clinic
M.D. Anderson Cancer Center
Mayo Clinic
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Mayo Clinic
Roswell Park Cancer Institute
Mayo Clinic
University of Chicago
Case Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
Case Comprehensive Cancer Center
Wake Forest University Health Sciences
Wake Forest University Health Sciences
University of Arizona
Ohio State University Comprehensive Cancer Center
Beth Israel Deaconess Medical Center
OHSU Knight Cancer Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Massachusetts General Hospital
University of Washington
Fred Hutchinson Cancer Center
University of Washington
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Alliance for Clinical Trials in Oncology
Mayo Clinic